Patent Ductus Arteriosus (PDA)

01Pathophysiology

The ductus arteriosus is a normal fetal vascular structure connecting the pulmonary artery to the descending aorta. During fetal life, this channel diverts blood away from the high-resistance, fluid-filled lungs and directs it toward the placenta for gas exchange. Two factors keep the ductus open in utero: low oxygen tension in fetal blood and circulating prostaglandin E2 (produced primarily by the placenta).

At birth, two events trigger ductal closure. First, the infant's first breaths cause a rise in arterial oxygen tension ($Pa{O}_{2}PaO\_2$), which directly constricts the smooth muscle of the ductal wall. Second, removal of the placenta eliminates the primary source of prostaglandin E2, lowering its circulating levels. The combination of increased oxygen and decreased prostaglandin leads to functional closure within 24 to 72 hours, followed by anatomical closure (fibrosis into the ligamentum arteriosum) over the next 2 to 3 weeks.

In PDA, this closure fails. Because aortic pressure exceeds pulmonary artery pressure after birth, blood shunts left-to-right (aorta to pulmonary artery) through the open ductus. This creates a volume overload on the pulmonary vasculature and the left heart (left atrium and left ventricle), since the excess blood returns via the pulmonary veins. Over time, the left atrium and left ventricle dilate. The continuous pressure gradient between the aorta and pulmonary artery (present in both systole and diastole) is what produces the characteristic continuous machinery murmur. The murmur is continuous because, unlike most left-to-right shunts, the aortic pressure remains higher than pulmonary artery pressure throughout the entire cardiac cycle.

The widened pulse pressure and bounding pulses occur because blood "runs off" from the aorta into the lower-resistance pulmonary circulation during diastole, causing the diastolic pressure to drop while systolic pressure is maintained or even elevated due to the increased stroke volume from left ventricular volume overload.

Premature infants are especially vulnerable because their ductal tissue is more sensitive to prostaglandins and less responsive to oxygen-mediated constriction. This is why pharmacologic intervention with prostaglandin synthesis inhibitors (NSAIDs) is effective in this population.

If left uncorrected, a large PDA can eventually cause pulmonary vascular remodeling and Eisenmenger syndrome, where pulmonary pressures exceed systemic pressures and the shunt reverses to right-to-left. At this point, differential cyanosis appears: the lower extremities (supplied by the descending aorta, which receives deoxygenated blood from the pulmonary artery via the reversed ductus) become cyanotic, while the upper extremities and head (supplied by the aortic arch proximal to the ductus) remain pink.

02Classification and Clinical Manifestation

In premature neonates, the presentation is often a failure to wean from ventilatory support, worsening respiratory status, apneic episodes, and hemodynamic instability with bounding pulses and a hyperdynamic precordium rather than the classic murmur heard in older infants.

03Diagnostic Workup

Echocardiography is the cornerstone of PDA diagnosis. It is noninvasive, widely available, and provides all the information needed: ductus size, shunt direction, volume of left heart overload, and estimated pulmonary artery pressures. In nearly all clinical and exam scenarios, echocardiography is both the best initial and the most accurate test.

Chest X-ray is often the first study obtained when an infant presents with respiratory symptoms or a murmur. In PDA, the X-ray shows signs of left heart volume overload: cardiomegaly with prominent pulmonary vasculature. However, the X-ray is nondiagnostic for PDA and serves only to raise suspicion.

Cardiac catheterization is not routinely needed. Its role is limited to cases where the degree of pulmonary hypertension is uncertain and you need to determine whether the pulmonary vascular changes are still reversible before considering closure. A step-up in oxygen saturation at the level of the pulmonary artery (compared to the right ventricle) confirms a left-to-right shunt at the ductal level.

From a test-writer perspective, if you are given a premature neonate with a continuous murmur, bounding pulses, and widened pulse pressure, the next best step is echocardiography. Do not be distracted by answer choices suggesting catheterization or CT angiography.

04Management and Treatment

Contraindications to indomethacin and ibuprofen (but not to paracetamol): necrotizing enterocolitis (NEC) or suspected NEC, active renal insufficiency (serum creatinine above 1.6 to 1.8 mg/dL), platelet count below 50,000/mcL, active bleeding including intracranial hemorrhage, and ductal-dependent cardiac lesions. This is a key advantage of paracetamol: in scenarios where COX inhibitors are contraindicated due to renal failure, thrombocytopenia, or NEC, paracetamol remains a viable pharmacologic option before resorting to surgical intervention. The only shared contraindication across all three agents is ductal-dependent cardiac lesions, and the only contraindication relatively unique to paracetamol is severe hepatic dysfunction.

Critical exam concept: indomethacin/ibuprofen/paracetamol close the PDA, while prostaglandin E1 keeps it open. These drugs work in opposite directions, and test-writers frequently present scenarios requiring you to decide which one to use. If a newborn has cyanotic heart disease depending on ductal flow for survival, the answer is prostaglandin E1. If a premature infant has a symptomatic PDA causing heart failure or ventilator dependence, the answer is paracetamol (or ibuprofen/indomethacin). If the question stem includes renal insufficiency or thrombocytopenia alongside a symptomatic PDA, they are steering you toward paracetamol as the answer.

Endocarditis prophylaxis is recommended for the first 6 months after transcatheter device closure or surgical ligation, or indefinitely if there is a residual shunt adjacent to prosthetic material.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The single most tested trap in PDA questions is confusing when to close the ductus versus when to keep it open. A premature baby with a continuous murmur, bounding pulses, and respiratory distress needs the ductus closed (indomethacin or ibuprofen). A cyanotic newborn with a ductal-dependent lesion (e.g., transposition of great arteries, critical pulmonary stenosis, hypoplastic left heart syndrome) needs the ductus kept open with prostaglandin E1. Test-writers will present both scenarios and expect you to choose the correct drug. Selecting indomethacin for a ductal-dependent lesion or prostaglandin E1 for a symptomatic PDA is a frequently exploited error.

Another common trap involves the murmur description. Students who memorize "continuous murmur equals PDA" may overlook that a venous hum is also continuous. The distinguishing features are that a venous hum changes with position and head rotation, while the PDA machinery murmur does not. If the vignette describes a healthy child with a continuous murmur that disappears when lying down, the answer is a benign venous hum, not PDA.

Watch for questions about Eisenmenger physiology in the setting of PDA. Once the shunt reverses, closure is contraindicated. A question may describe a patient with PDA and long-standing pulmonary hypertension who now has differential cyanosis (blue toes, pink fingers). This is the signal for irreversible Eisenmenger syndrome, and the correct answer is medical management only, not surgery or device closure.

Finally, remember that NSAIDs work only in premature infants. If a term infant or older child is described with a PDA, the correct treatment is transcatheter device closure or surgical ligation. Choosing indomethacin for a 2-year-old with PDA is incorrect and is a favorite wrong answer on exams.